These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 19601885)

  • 21. HIV-1 antiretroviral drug therapy.
    Arts EJ; Hazuda DJ
    Cold Spring Harb Perspect Med; 2012 Apr; 2(4):a007161. PubMed ID: 22474613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical implications of resistance to antiretrovirals: new resistance technologies and interpretations.
    Mascolini M; Richman D; Larder B; Mellors J; Boucher CA
    Antivir Ther; 2008; 13(2):319-34. PubMed ID: 18505183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigational antiretroviral drugs.
    Sen S; Mathur AG; Gupta RM; Kapila K; Chopra GS
    Recent Pat Antiinfect Drug Discov; 2008 Nov; 3(3):199-205. PubMed ID: 18991802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Why switch from protease inhibitors (PI) to non-nucleoside reverse transcriptase inhibitors (NNRTI)?
    Pozniak AL
    HIV Med; 2000; 1 Suppl 1():7-10. PubMed ID: 11737361
    [No Abstract]   [Full Text] [Related]  

  • 25. HIV/AIDS management in office practice. Antiretroviral therapy.
    Hartman AF
    Prim Care; 1997 Sep; 24(3):531-60. PubMed ID: 9271691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Small-molecule antagonists of CCR5 and CXCR4: a promising new class of anti-HIV-1 drugs.
    Seibert C; Sakmar TP
    Curr Pharm Des; 2004; 10(17):2041-62. PubMed ID: 15279544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemokine receptor-directed agents as novel anti-HIV-1 therapies.
    Mills SG; DeMartino JA
    Curr Top Med Chem; 2004; 4(10):1017-33. PubMed ID: 15193136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors.
    Hecht FM; Grant RM; Petropoulos CJ; Dillon B; Chesney MA; Tian H; Hellmann NS; Bandrapalli NI; Digilio L; Branson B; Kahn JO
    N Engl J Med; 1998 Jul; 339(5):307-11. PubMed ID: 9682043
    [No Abstract]   [Full Text] [Related]  

  • 29. [Recent progress in anti-HIM-1 research].
    Baba M
    Uirusu; 2004 Jun; 54(1):59-66. PubMed ID: 15449905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pregnancy and neonatal outcomes in women with HIV-1 exposed to integrase inhibitors, protease inhibitors and non-nucleoside reverse transcriptase inhibitors: an observational study.
    Floridia M; Dalzero S; Giacomet V; Tamburrini E; Masuelli G; Savasi V; Spinillo A; Tassis B; Franceschetti L; Degli Antoni AM; Sansone M; Guaraldi G; Vimercati A; Meloni A; Ravizza M;
    Infection; 2020 Apr; 48(2):249-258. PubMed ID: 31893354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Action of anti-HIV drugs and resistance: reverse transcriptase inhibitors and protease inhibitors.
    Imamichi T
    Curr Pharm Des; 2004; 10(32):4039-53. PubMed ID: 15579086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The clinical pharmacology of antiretrovirals in development.
    Winston A; Mallon PW; Boffito M
    Expert Opin Drug Metab Toxicol; 2006 Jun; 2(3):447-58. PubMed ID: 16863445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV entry inhibitors: progress in development and application.
    Lai WH; Huang L; Chen CH
    Yao Xue Xue Bao; 2010 Feb; 45(2):131-40. PubMed ID: 21348414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New drugs: attacking chemokine receptors.
    Flexner C
    Hopkins HIV Rep; 2002 Mar; 14(2):12. PubMed ID: 12030210
    [No Abstract]   [Full Text] [Related]  

  • 35. Progress of bis(heteroaryl)piperazines (BHAPs) as non-nucleoside reverse transcriptase inhibitors (NNRTIs) against human immunodeficiency virus type 1 (HIV-1).
    Xu H
    Mini Rev Med Chem; 2010 Jan; 10(1):62-72. PubMed ID: 20380641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV-chemotherapy and -prophylaxis: new drugs, leads and approaches.
    De Clercq E
    Int J Biochem Cell Biol; 2004 Sep; 36(9):1800-22. PubMed ID: 15183346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV chemokine receptor inhibitors as novel anti-HIV drugs.
    Princen K; Schols D
    Cytokine Growth Factor Rev; 2005 Dec; 16(6):659-77. PubMed ID: 16005254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Review of HIV antiretroviral drug resistance.
    Chen TK; Aldrovandi GM
    Pediatr Infect Dis J; 2008 Aug; 27(8):749-52. PubMed ID: 18664987
    [No Abstract]   [Full Text] [Related]  

  • 39. Antiretroviral resistance.
    Geretti AM
    J HIV Ther; 2006 Dec; 11(4):72-3. PubMed ID: 17578209
    [No Abstract]   [Full Text] [Related]  

  • 40. [7th Conference on Retroviruses and Opportunistic Infections].
    De Wit S
    Rev Med Brux; 2000 Dec; 21(6):A521-3. PubMed ID: 11194504
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.